Kazuo Mimura

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 300 citations

Non-pharmacological Intervention, Diabetes Management, Cardiovascular Disease +9

Effects of a New Oral Hypoglycaemic Agent (CS‐045) on Metabolic Abnormalities and Insulin Resistance in Type 2 Diabetes

Kazuo Mimura, F. Umeda, S. Hiramatsu et al. · Diabetic Medicine · 1994 · 89 citations

Insulin Signaling, Obesity, Metabolic Syndrome +17

Activation of Proteases in Cerulein-Induced Pancreatitis

Hiroya Yamaguchi, Toshinari Kimura, Kazuo Mimura et al. · Pancreas · 1989 · 87 citations

Interstitial Muscle Insulin and Glucose Levels in Normal and Insulin-Resistant Zucker Rats

Agneta Holmäng, Kazuo Mimura, Per Björntorp et al. · Diabetes · 1997 · 53 citations

Insulin Signaling, Metabolic Syndrome, Body Composition +20

Corticotropin-Releasing Hormone- and Adrenocorticotropin-Producing Pituitary Carcinoma with Metastases to the Liver and Lung in a Patient with Cushing's Disease*

Hajime Nawata, Kazumi Higuchi, Shoichiro Ikuyama et al. · The Journal of Clinical Endocrinology & Metabolism · 1990 · 50 citations

Endocrine Oncology, Urology, Pituitary Gland +14